Pharma & Healthcare
Global Quetiapine Fumarate Market Research Report 2026
- Jan 17, 26
- ID: 687906
- Pages: 123
- Figures: 124
- Views: 3
This report delivers a comprehensive overview of the global Quetiapine Fumarate market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Quetiapine Fumarate. The Quetiapine Fumarate market size, estimates, and forecasts are provided in terms of sales volume (MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Quetiapine Fumarate market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Quetiapine Fumarate manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Segment by Type
Immediate Release Tablets
Extended Release Tablets
by Application
Adult
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Quetiapine Fumarate manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Quetiapine Fumarate sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Quetiapine Fumarate market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Quetiapine Fumarate manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Segment by Type
Immediate Release Tablets
Extended Release Tablets
by Application
Adult
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Quetiapine Fumarate manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Quetiapine Fumarate sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Quetiapine Fumarate Market Overview
1.1 Product Definition
1.2 Quetiapine Fumarate by Type
1.2.1 Global Quetiapine Fumarate Market Value by Type: 2025 vs 2032
1.2.2 Immediate Release Tablets
1.2.3 Extended Release Tablets
1.3 Quetiapine Fumarate by Application
1.3.1 Global Quetiapine Fumarate Market Value by Application: 2025 vs 2032
1.3.2 Adult
1.3.3 Others
1.4 Global Quetiapine Fumarate Market Size Estimates and Forecasts
1.4.1 Global Quetiapine Fumarate Revenue 2021–2032
1.4.2 Global Quetiapine Fumarate Sales 2021–2032
1.4.3 Global Quetiapine Fumarate Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Quetiapine Fumarate Market Competition by Manufacturers
2.1 Global Quetiapine Fumarate Sales Market Share by Manufacturers (2021–2026)
2.2 Global Quetiapine Fumarate Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Quetiapine Fumarate Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Quetiapine Fumarate, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Quetiapine Fumarate, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Quetiapine Fumarate, Product Types and Applications
2.7 Global Key Manufacturers of Quetiapine Fumarate, Date of Entry into the Industry
2.8 Global Quetiapine Fumarate Market Competitive Situation and Trends
2.8.1 Global Quetiapine Fumarate Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Quetiapine Fumarate Players Market Share by Revenue
2.8.3 Global Quetiapine Fumarate Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Quetiapine Fumarate Market Scenario by Region
3.1 Global Quetiapine Fumarate Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Quetiapine Fumarate Sales by Region: 2021–2032
3.2.1 Global Quetiapine Fumarate Sales by Region: 2021–2026
3.2.2 Global Quetiapine Fumarate Sales by Region: 2027–2032
3.3 Global Quetiapine Fumarate Revenue by Region: 2021–2032
3.3.1 Global Quetiapine Fumarate Revenue by Region: 2021–2026
3.3.2 Global Quetiapine Fumarate Revenue by Region: 2027–2032
3.4 North America Quetiapine Fumarate Market Facts & Figures by Country
3.4.1 North America Quetiapine Fumarate Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Quetiapine Fumarate Sales by Country (2021–2032)
3.4.3 North America Quetiapine Fumarate Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Quetiapine Fumarate Market Facts & Figures by Country
3.5.1 Europe Quetiapine Fumarate Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Quetiapine Fumarate Sales by Country (2021–2032)
3.5.3 Europe Quetiapine Fumarate Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Quetiapine Fumarate Market Facts & Figures by Region
3.6.1 Asia Pacific Quetiapine Fumarate Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Quetiapine Fumarate Sales by Region (2021–2032)
3.6.3 Asia Pacific Quetiapine Fumarate Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Quetiapine Fumarate Market Facts & Figures by Country
3.7.1 Latin America Quetiapine Fumarate Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Quetiapine Fumarate Sales by Country (2021–2032)
3.7.3 Latin America Quetiapine Fumarate Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Quetiapine Fumarate Market Facts & Figures by Country
3.8.1 Middle East and Africa Quetiapine Fumarate Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Quetiapine Fumarate Sales by Country (2021–2032)
3.8.3 Middle East and Africa Quetiapine Fumarate Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Quetiapine Fumarate Sales by Type (2021–2032)
4.1.1 Global Quetiapine Fumarate Sales by Type (2021–2026)
4.1.2 Global Quetiapine Fumarate Sales by Type (2027–2032)
4.1.3 Global Quetiapine Fumarate Sales Market Share by Type (2021–2032)
4.2 Global Quetiapine Fumarate Revenue by Type (2021–2032)
4.2.1 Global Quetiapine Fumarate Revenue by Type (2021–2026)
4.2.2 Global Quetiapine Fumarate Revenue by Type (2027–2032)
4.2.3 Global Quetiapine Fumarate Revenue Market Share by Type (2021–2032)
4.3 Global Quetiapine Fumarate Price by Type (2021–2032)
5 Segment by Application
5.1 Global Quetiapine Fumarate Sales by Application (2021–2032)
5.1.1 Global Quetiapine Fumarate Sales by Application (2021–2026)
5.1.2 Global Quetiapine Fumarate Sales by Application (2027–2032)
5.1.3 Global Quetiapine Fumarate Sales Market Share by Application (2021–2032)
5.2 Global Quetiapine Fumarate Revenue by Application (2021–2032)
5.2.1 Global Quetiapine Fumarate Revenue by Application (2021–2026)
5.2.2 Global Quetiapine Fumarate Revenue by Application (2027–2032)
5.2.3 Global Quetiapine Fumarate Revenue Market Share by Application (2021–2032)
5.3 Global Quetiapine Fumarate Price by Application (2021–2032)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 AstraZeneca Quetiapine Fumarate Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Intas
6.2.1 Intas Company Information
6.2.2 Intas Description and Business Overview
6.2.3 Intas Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Intas Quetiapine Fumarate Product Portfolio
6.2.5 Intas Recent Developments/Updates
6.3 TAPI
6.3.1 TAPI Company Information
6.3.2 TAPI Description and Business Overview
6.3.3 TAPI Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 TAPI Quetiapine Fumarate Product Portfolio
6.3.5 TAPI Recent Developments/Updates
6.4 Accord
6.4.1 Accord Company Information
6.4.2 Accord Description and Business Overview
6.4.3 Accord Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Accord Quetiapine Fumarate Product Portfolio
6.4.5 Accord Recent Developments/Updates
6.5 Hexal
6.5.1 Hexal Company Information
6.5.2 Hexal Description and Business Overview
6.5.3 Hexal Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Hexal Quetiapine Fumarate Product Portfolio
6.5.5 Hexal Recent Developments/Updates
6.6 Dr.Reddy's
6.6.1 Dr.Reddy's Company Information
6.6.2 Dr.Reddy's Description and Business Overview
6.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Dr.Reddy's Quetiapine Fumarate Product Portfolio
6.6.5 Dr.Reddy's Recent Developments/Updates
6.7 Lupin
6.7.1 Lupin Company Information
6.7.2 Lupin Description and Business Overview
6.7.3 Lupin Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Lupin Quetiapine Fumarate Product Portfolio
6.7.5 Lupin Recent Developments/Updates
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Company Information
6.8.2 Sun Pharmaceutical Description and Business Overview
6.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sun Pharmaceutical Quetiapine Fumarate Product Portfolio
6.8.5 Sun Pharmaceutical Recent Developments/Updates
6.9 Hunan Dongting Pharm
6.9.1 Hunan Dongting Pharm Company Information
6.9.2 Hunan Dongting Pharm Description and Business Overview
6.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hunan Dongting Pharm Quetiapine Fumarate Product Portfolio
6.9.5 Hunan Dongting Pharm Recent Developments/Updates
6.10 SuZhou NO.4 Phamaceutical Factory
6.10.1 SuZhou NO.4 Phamaceutical Factory Company Information
6.10.2 SuZhou NO.4 Phamaceutical Factory Description and Business Overview
6.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolio
6.10.5 SuZhou NO.4 Phamaceutical Factory Recent Developments/Updates
6.11 Fuan Pharmaceutical
6.11.1 Fuan Pharmaceutical Company Information
6.11.2 Fuan Pharmaceutical Description and Business Overview
6.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Fuan Pharmaceutical Quetiapine Fumarate Product Portfolio
6.11.5 Fuan Pharmaceutical Recent Developments/Updates
6.12 Zhejiang Supor Pharmaceuticals
6.12.1 Zhejiang Supor Pharmaceuticals Company Information
6.12.2 Zhejiang Supor Pharmaceuticals Description and Business Overview
6.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolio
6.12.5 Zhejiang Supor Pharmaceuticals Recent Developments/Updates
6.13 Zhejiang Huahai Pharmaceutical
6.13.1 Zhejiang Huahai Pharmaceutical Company Information
6.13.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
6.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolio
6.13.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Quetiapine Fumarate Industry Chain Analysis
7.2 Quetiapine Fumarate Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Quetiapine Fumarate Production Mode & Process Analysis
7.4 Quetiapine Fumarate Sales and Marketing
7.4.1 Quetiapine Fumarate Sales Channels
7.4.2 Quetiapine Fumarate Distributors
7.5 Quetiapine Fumarate Customer Analysis
8 Quetiapine Fumarate Market Dynamics
8.1 Quetiapine Fumarate Industry Trends
8.2 Quetiapine Fumarate Market Drivers
8.3 Quetiapine Fumarate Market Challenges
8.4 Quetiapine Fumarate Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Quetiapine Fumarate by Type
1.2.1 Global Quetiapine Fumarate Market Value by Type: 2025 vs 2032
1.2.2 Immediate Release Tablets
1.2.3 Extended Release Tablets
1.3 Quetiapine Fumarate by Application
1.3.1 Global Quetiapine Fumarate Market Value by Application: 2025 vs 2032
1.3.2 Adult
1.3.3 Others
1.4 Global Quetiapine Fumarate Market Size Estimates and Forecasts
1.4.1 Global Quetiapine Fumarate Revenue 2021–2032
1.4.2 Global Quetiapine Fumarate Sales 2021–2032
1.4.3 Global Quetiapine Fumarate Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Quetiapine Fumarate Market Competition by Manufacturers
2.1 Global Quetiapine Fumarate Sales Market Share by Manufacturers (2021–2026)
2.2 Global Quetiapine Fumarate Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Quetiapine Fumarate Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Quetiapine Fumarate, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Quetiapine Fumarate, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Quetiapine Fumarate, Product Types and Applications
2.7 Global Key Manufacturers of Quetiapine Fumarate, Date of Entry into the Industry
2.8 Global Quetiapine Fumarate Market Competitive Situation and Trends
2.8.1 Global Quetiapine Fumarate Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Quetiapine Fumarate Players Market Share by Revenue
2.8.3 Global Quetiapine Fumarate Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Quetiapine Fumarate Market Scenario by Region
3.1 Global Quetiapine Fumarate Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Quetiapine Fumarate Sales by Region: 2021–2032
3.2.1 Global Quetiapine Fumarate Sales by Region: 2021–2026
3.2.2 Global Quetiapine Fumarate Sales by Region: 2027–2032
3.3 Global Quetiapine Fumarate Revenue by Region: 2021–2032
3.3.1 Global Quetiapine Fumarate Revenue by Region: 2021–2026
3.3.2 Global Quetiapine Fumarate Revenue by Region: 2027–2032
3.4 North America Quetiapine Fumarate Market Facts & Figures by Country
3.4.1 North America Quetiapine Fumarate Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Quetiapine Fumarate Sales by Country (2021–2032)
3.4.3 North America Quetiapine Fumarate Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Quetiapine Fumarate Market Facts & Figures by Country
3.5.1 Europe Quetiapine Fumarate Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Quetiapine Fumarate Sales by Country (2021–2032)
3.5.3 Europe Quetiapine Fumarate Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Quetiapine Fumarate Market Facts & Figures by Region
3.6.1 Asia Pacific Quetiapine Fumarate Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Quetiapine Fumarate Sales by Region (2021–2032)
3.6.3 Asia Pacific Quetiapine Fumarate Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Quetiapine Fumarate Market Facts & Figures by Country
3.7.1 Latin America Quetiapine Fumarate Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Quetiapine Fumarate Sales by Country (2021–2032)
3.7.3 Latin America Quetiapine Fumarate Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Quetiapine Fumarate Market Facts & Figures by Country
3.8.1 Middle East and Africa Quetiapine Fumarate Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Quetiapine Fumarate Sales by Country (2021–2032)
3.8.3 Middle East and Africa Quetiapine Fumarate Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Quetiapine Fumarate Sales by Type (2021–2032)
4.1.1 Global Quetiapine Fumarate Sales by Type (2021–2026)
4.1.2 Global Quetiapine Fumarate Sales by Type (2027–2032)
4.1.3 Global Quetiapine Fumarate Sales Market Share by Type (2021–2032)
4.2 Global Quetiapine Fumarate Revenue by Type (2021–2032)
4.2.1 Global Quetiapine Fumarate Revenue by Type (2021–2026)
4.2.2 Global Quetiapine Fumarate Revenue by Type (2027–2032)
4.2.3 Global Quetiapine Fumarate Revenue Market Share by Type (2021–2032)
4.3 Global Quetiapine Fumarate Price by Type (2021–2032)
5 Segment by Application
5.1 Global Quetiapine Fumarate Sales by Application (2021–2032)
5.1.1 Global Quetiapine Fumarate Sales by Application (2021–2026)
5.1.2 Global Quetiapine Fumarate Sales by Application (2027–2032)
5.1.3 Global Quetiapine Fumarate Sales Market Share by Application (2021–2032)
5.2 Global Quetiapine Fumarate Revenue by Application (2021–2032)
5.2.1 Global Quetiapine Fumarate Revenue by Application (2021–2026)
5.2.2 Global Quetiapine Fumarate Revenue by Application (2027–2032)
5.2.3 Global Quetiapine Fumarate Revenue Market Share by Application (2021–2032)
5.3 Global Quetiapine Fumarate Price by Application (2021–2032)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 AstraZeneca Quetiapine Fumarate Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Intas
6.2.1 Intas Company Information
6.2.2 Intas Description and Business Overview
6.2.3 Intas Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Intas Quetiapine Fumarate Product Portfolio
6.2.5 Intas Recent Developments/Updates
6.3 TAPI
6.3.1 TAPI Company Information
6.3.2 TAPI Description and Business Overview
6.3.3 TAPI Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 TAPI Quetiapine Fumarate Product Portfolio
6.3.5 TAPI Recent Developments/Updates
6.4 Accord
6.4.1 Accord Company Information
6.4.2 Accord Description and Business Overview
6.4.3 Accord Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Accord Quetiapine Fumarate Product Portfolio
6.4.5 Accord Recent Developments/Updates
6.5 Hexal
6.5.1 Hexal Company Information
6.5.2 Hexal Description and Business Overview
6.5.3 Hexal Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Hexal Quetiapine Fumarate Product Portfolio
6.5.5 Hexal Recent Developments/Updates
6.6 Dr.Reddy's
6.6.1 Dr.Reddy's Company Information
6.6.2 Dr.Reddy's Description and Business Overview
6.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Dr.Reddy's Quetiapine Fumarate Product Portfolio
6.6.5 Dr.Reddy's Recent Developments/Updates
6.7 Lupin
6.7.1 Lupin Company Information
6.7.2 Lupin Description and Business Overview
6.7.3 Lupin Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Lupin Quetiapine Fumarate Product Portfolio
6.7.5 Lupin Recent Developments/Updates
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Company Information
6.8.2 Sun Pharmaceutical Description and Business Overview
6.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sun Pharmaceutical Quetiapine Fumarate Product Portfolio
6.8.5 Sun Pharmaceutical Recent Developments/Updates
6.9 Hunan Dongting Pharm
6.9.1 Hunan Dongting Pharm Company Information
6.9.2 Hunan Dongting Pharm Description and Business Overview
6.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hunan Dongting Pharm Quetiapine Fumarate Product Portfolio
6.9.5 Hunan Dongting Pharm Recent Developments/Updates
6.10 SuZhou NO.4 Phamaceutical Factory
6.10.1 SuZhou NO.4 Phamaceutical Factory Company Information
6.10.2 SuZhou NO.4 Phamaceutical Factory Description and Business Overview
6.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolio
6.10.5 SuZhou NO.4 Phamaceutical Factory Recent Developments/Updates
6.11 Fuan Pharmaceutical
6.11.1 Fuan Pharmaceutical Company Information
6.11.2 Fuan Pharmaceutical Description and Business Overview
6.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Fuan Pharmaceutical Quetiapine Fumarate Product Portfolio
6.11.5 Fuan Pharmaceutical Recent Developments/Updates
6.12 Zhejiang Supor Pharmaceuticals
6.12.1 Zhejiang Supor Pharmaceuticals Company Information
6.12.2 Zhejiang Supor Pharmaceuticals Description and Business Overview
6.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolio
6.12.5 Zhejiang Supor Pharmaceuticals Recent Developments/Updates
6.13 Zhejiang Huahai Pharmaceutical
6.13.1 Zhejiang Huahai Pharmaceutical Company Information
6.13.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
6.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolio
6.13.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Quetiapine Fumarate Industry Chain Analysis
7.2 Quetiapine Fumarate Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Quetiapine Fumarate Production Mode & Process Analysis
7.4 Quetiapine Fumarate Sales and Marketing
7.4.1 Quetiapine Fumarate Sales Channels
7.4.2 Quetiapine Fumarate Distributors
7.5 Quetiapine Fumarate Customer Analysis
8 Quetiapine Fumarate Market Dynamics
8.1 Quetiapine Fumarate Industry Trends
8.2 Quetiapine Fumarate Market Drivers
8.3 Quetiapine Fumarate Market Challenges
8.4 Quetiapine Fumarate Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Quetiapine Fumarate Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Quetiapine Fumarate Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Quetiapine Fumarate Market Competitive Situation by Manufacturers in 2025
Table 4. Global Quetiapine Fumarate Sales (MT) of Key Manufacturers (2021–2026)
Table 5. Global Quetiapine Fumarate Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Quetiapine Fumarate Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Quetiapine Fumarate Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Quetiapine Fumarate Average Price (USD/Kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Quetiapine Fumarate, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Quetiapine Fumarate, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Quetiapine Fumarate, Product Types and Applications
Table 12. Global Key Manufacturers of Quetiapine Fumarate, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Quetiapine Fumarate Companies by Tier (Tier 1, Tier 2, Tier 3), based on Quetiapine Fumarate Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Quetiapine Fumarate Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Quetiapine Fumarate Sales by Region (MT), 2021–2026
Table 18. Global Quetiapine Fumarate Sales Market Share by Region (2021–2026)
Table 19. Global Quetiapine Fumarate Sales by Region (MT), 2027–2032
Table 20. Global Quetiapine Fumarate Sales Market Share by Region (2027–2032)
Table 21. Global Quetiapine Fumarate Revenue by Region (US$ Million), 2021–2026
Table 22. Global Quetiapine Fumarate Revenue Market Share by Region (2021–2026)
Table 23. Global Quetiapine Fumarate Revenue by Region (US$ Million), 2027–2032
Table 24. Global Quetiapine Fumarate Revenue Market Share by Region (2027–2032)
Table 25. North America Quetiapine Fumarate Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Quetiapine Fumarate Sales by Country (MT), 2021–2026
Table 27. North America Quetiapine Fumarate Sales by Country (MT), 2027–2032
Table 28. North America Quetiapine Fumarate Revenue by Country (US$ Million), 2021–2026
Table 29. North America Quetiapine Fumarate Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Quetiapine Fumarate Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Quetiapine Fumarate Sales by Country (MT), 2021–2026
Table 32. Europe Quetiapine Fumarate Sales by Country (MT), 2027–2032
Table 33. Europe Quetiapine Fumarate Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Quetiapine Fumarate Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Quetiapine Fumarate Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Quetiapine Fumarate Sales by Region (MT), 2021–2026
Table 37. Asia Pacific Quetiapine Fumarate Sales by Region (MT), 2027–2032
Table 38. Asia Pacific Quetiapine Fumarate Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Quetiapine Fumarate Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Quetiapine Fumarate Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Quetiapine Fumarate Sales by Country (MT), 2021–2026
Table 42. Latin America Quetiapine Fumarate Sales by Country (MT), 2027–2032
Table 43. Latin America Quetiapine Fumarate Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Quetiapine Fumarate Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Quetiapine Fumarate Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Quetiapine Fumarate Sales by Country (MT), 2021–2026
Table 47. Middle East and Africa Quetiapine Fumarate Sales by Country (MT), 2027–2032
Table 48. Middle East and Africa Quetiapine Fumarate Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Quetiapine Fumarate Revenue by Country (US$ Million), 2027–2032
Table 50. Global Quetiapine Fumarate Sales (MT) by Type (2021–2026)
Table 51. Global Quetiapine Fumarate Sales (MT) by Type (2027–2032)
Table 52. Global Quetiapine Fumarate Sales Market Share by Type (2021–2026)
Table 53. Global Quetiapine Fumarate Sales Market Share by Type (2027–2032)
Table 54. Global Quetiapine Fumarate Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Quetiapine Fumarate Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Quetiapine Fumarate Revenue Market Share by Type (2021–2026)
Table 57. Global Quetiapine Fumarate Revenue Market Share by Type (2027–2032)
Table 58. Global Quetiapine Fumarate Price (USD/Kg) by Type (2021–2026)
Table 59. Global Quetiapine Fumarate Price (USD/Kg) by Type (2027–2032)
Table 60. Global Quetiapine Fumarate Sales (MT) by Application (2021–2026)
Table 61. Global Quetiapine Fumarate Sales (MT) by Application (2027–2032)
Table 62. Global Quetiapine Fumarate Sales Market Share by Application (2021–2026)
Table 63. Global Quetiapine Fumarate Sales Market Share by Application (2027–2032)
Table 64. Global Quetiapine Fumarate Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Quetiapine Fumarate Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Quetiapine Fumarate Revenue Market Share by Application (2021–2026)
Table 67. Global Quetiapine Fumarate Revenue Market Share by Application (2027–2032)
Table 68. Global Quetiapine Fumarate Price (USD/Kg) by Application (2021–2026)
Table 69. Global Quetiapine Fumarate Price (USD/Kg) by Application (2027–2032)
Table 70. AstraZeneca Company Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 73. AstraZeneca Quetiapine Fumarate Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Intas Company Information
Table 76. Intas Description and Business Overview
Table 77. Intas Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 78. Intas Quetiapine Fumarate Product
Table 79. Intas Recent Developments/Updates
Table 80. TAPI Company Information
Table 81. TAPI Description and Business Overview
Table 82. TAPI Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 83. TAPI Quetiapine Fumarate Product
Table 84. TAPI Recent Developments/Updates
Table 85. Accord Company Information
Table 86. Accord Description and Business Overview
Table 87. Accord Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 88. Accord Quetiapine Fumarate Product
Table 89. Accord Recent Developments/Updates
Table 90. Hexal Company Information
Table 91. Hexal Description and Business Overview
Table 92. Hexal Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 93. Hexal Quetiapine Fumarate Product
Table 94. Hexal Recent Developments/Updates
Table 95. Dr.Reddy's Company Information
Table 96. Dr.Reddy's Description and Business Overview
Table 97. Dr.Reddy's Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 98. Dr.Reddy's Quetiapine Fumarate Product
Table 99. Dr.Reddy's Recent Developments/Updates
Table 100. Lupin Company Information
Table 101. Lupin Description and Business Overview
Table 102. Lupin Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 103. Lupin Quetiapine Fumarate Product
Table 104. Lupin Recent Developments/Updates
Table 105. Sun Pharmaceutical Company Information
Table 106. Sun Pharmaceutical Description and Business Overview
Table 107. Sun Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 108. Sun Pharmaceutical Quetiapine Fumarate Product
Table 109. Sun Pharmaceutical Recent Developments/Updates
Table 110. Hunan Dongting Pharm Company Information
Table 111. Hunan Dongting Pharm Description and Business Overview
Table 112. Hunan Dongting Pharm Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 113. Hunan Dongting Pharm Quetiapine Fumarate Product
Table 114. Hunan Dongting Pharm Recent Developments/Updates
Table 115. SuZhou NO.4 Phamaceutical Factory Company Information
Table 116. SuZhou NO.4 Phamaceutical Factory Description and Business Overview
Table 117. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 118. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product
Table 119. SuZhou NO.4 Phamaceutical Factory Recent Developments/Updates
Table 120. Fuan Pharmaceutical Company Information
Table 121. Fuan Pharmaceutical Description and Business Overview
Table 122. Fuan Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 123. Fuan Pharmaceutical Quetiapine Fumarate Product
Table 124. Fuan Pharmaceutical Recent Developments/Updates
Table 125. Zhejiang Supor Pharmaceuticals Company Information
Table 126. Zhejiang Supor Pharmaceuticals Description and Business Overview
Table 127. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 128. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product
Table 129. Zhejiang Supor Pharmaceuticals Recent Developments/Updates
Table 130. Zhejiang Huahai Pharmaceutical Company Information
Table 131. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 132. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 133. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product
Table 134. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Quetiapine Fumarate Distributors List
Table 138. Quetiapine Fumarate Customers List
Table 139. Quetiapine Fumarate Market Trends
Table 140. Quetiapine Fumarate Market Drivers
Table 141. Quetiapine Fumarate Market Challenges
Table 142. Quetiapine Fumarate Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Quetiapine Fumarate
Figure 2. Global Quetiapine Fumarate Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Quetiapine Fumarate Market Share by Type: 2025 & 2032
Figure 4. Immediate Release Tablets Product Picture
Figure 5. Extended Release Tablets Product Picture
Figure 6. Global Quetiapine Fumarate Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Quetiapine Fumarate Market Share by Application: 2025 & 2032
Figure 8. Adult
Figure 9. Others
Figure 10. Global Quetiapine Fumarate Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Quetiapine Fumarate Market Size (US$ Million), 2021–2032
Figure 12. Global Quetiapine Fumarate Sales (MT), 2021–2032
Figure 13. Global Quetiapine Fumarate Average Price (USD/Kg), 2021–2032
Figure 14. Quetiapine Fumarate Report Years Considered
Figure 15. Quetiapine Fumarate Sales Share by Manufacturers in 2025
Figure 16. Global Quetiapine Fumarate Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Quetiapine Fumarate Players: Market Share by Revenue in Quetiapine Fumarate in 2025
Figure 18. Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Quetiapine Fumarate Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Quetiapine Fumarate Sales Market Share by Country (2021–2032)
Figure 21. North America Quetiapine Fumarate Revenue Market Share by Country (2021–2032)
Figure 22. U.S. Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Quetiapine Fumarate Sales Market Share by Country (2021–2032)
Figure 25. Europe Quetiapine Fumarate Revenue Market Share by Country (2021–2032)
Figure 26. Germany Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Quetiapine Fumarate Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Quetiapine Fumarate Revenue Market Share by Region (2021–2032)
Figure 33. China Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Taiwan Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Indonesia Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Thailand Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Malaysia Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Philippines Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Quetiapine Fumarate Sales Market Share by Country (2021–2032)
Figure 44. Latin America Quetiapine Fumarate Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Quetiapine Fumarate Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Quetiapine Fumarate Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. U.A.E Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Quetiapine Fumarate by Type (2021–2032)
Figure 54. Global Revenue Market Share of Quetiapine Fumarate by Type (2021–2032)
Figure 55. Global Quetiapine Fumarate Price (USD/Kg) by Type (2021–2032)
Figure 56. Global Sales Market Share of Quetiapine Fumarate by Application (2021–2032)
Figure 57. Global Revenue Market Share of Quetiapine Fumarate by Application (2021–2032)
Figure 58. Global Quetiapine Fumarate Price (USD/Kg) by Application (2021–2032)
Figure 59. Quetiapine Fumarate Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Quetiapine Fumarate Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Quetiapine Fumarate Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Quetiapine Fumarate Market Competitive Situation by Manufacturers in 2025
Table 4. Global Quetiapine Fumarate Sales (MT) of Key Manufacturers (2021–2026)
Table 5. Global Quetiapine Fumarate Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Quetiapine Fumarate Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Quetiapine Fumarate Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Quetiapine Fumarate Average Price (USD/Kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Quetiapine Fumarate, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Quetiapine Fumarate, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Quetiapine Fumarate, Product Types and Applications
Table 12. Global Key Manufacturers of Quetiapine Fumarate, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Quetiapine Fumarate Companies by Tier (Tier 1, Tier 2, Tier 3), based on Quetiapine Fumarate Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Quetiapine Fumarate Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Quetiapine Fumarate Sales by Region (MT), 2021–2026
Table 18. Global Quetiapine Fumarate Sales Market Share by Region (2021–2026)
Table 19. Global Quetiapine Fumarate Sales by Region (MT), 2027–2032
Table 20. Global Quetiapine Fumarate Sales Market Share by Region (2027–2032)
Table 21. Global Quetiapine Fumarate Revenue by Region (US$ Million), 2021–2026
Table 22. Global Quetiapine Fumarate Revenue Market Share by Region (2021–2026)
Table 23. Global Quetiapine Fumarate Revenue by Region (US$ Million), 2027–2032
Table 24. Global Quetiapine Fumarate Revenue Market Share by Region (2027–2032)
Table 25. North America Quetiapine Fumarate Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Quetiapine Fumarate Sales by Country (MT), 2021–2026
Table 27. North America Quetiapine Fumarate Sales by Country (MT), 2027–2032
Table 28. North America Quetiapine Fumarate Revenue by Country (US$ Million), 2021–2026
Table 29. North America Quetiapine Fumarate Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Quetiapine Fumarate Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Quetiapine Fumarate Sales by Country (MT), 2021–2026
Table 32. Europe Quetiapine Fumarate Sales by Country (MT), 2027–2032
Table 33. Europe Quetiapine Fumarate Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Quetiapine Fumarate Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Quetiapine Fumarate Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Quetiapine Fumarate Sales by Region (MT), 2021–2026
Table 37. Asia Pacific Quetiapine Fumarate Sales by Region (MT), 2027–2032
Table 38. Asia Pacific Quetiapine Fumarate Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Quetiapine Fumarate Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Quetiapine Fumarate Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Quetiapine Fumarate Sales by Country (MT), 2021–2026
Table 42. Latin America Quetiapine Fumarate Sales by Country (MT), 2027–2032
Table 43. Latin America Quetiapine Fumarate Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Quetiapine Fumarate Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Quetiapine Fumarate Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Quetiapine Fumarate Sales by Country (MT), 2021–2026
Table 47. Middle East and Africa Quetiapine Fumarate Sales by Country (MT), 2027–2032
Table 48. Middle East and Africa Quetiapine Fumarate Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Quetiapine Fumarate Revenue by Country (US$ Million), 2027–2032
Table 50. Global Quetiapine Fumarate Sales (MT) by Type (2021–2026)
Table 51. Global Quetiapine Fumarate Sales (MT) by Type (2027–2032)
Table 52. Global Quetiapine Fumarate Sales Market Share by Type (2021–2026)
Table 53. Global Quetiapine Fumarate Sales Market Share by Type (2027–2032)
Table 54. Global Quetiapine Fumarate Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Quetiapine Fumarate Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Quetiapine Fumarate Revenue Market Share by Type (2021–2026)
Table 57. Global Quetiapine Fumarate Revenue Market Share by Type (2027–2032)
Table 58. Global Quetiapine Fumarate Price (USD/Kg) by Type (2021–2026)
Table 59. Global Quetiapine Fumarate Price (USD/Kg) by Type (2027–2032)
Table 60. Global Quetiapine Fumarate Sales (MT) by Application (2021–2026)
Table 61. Global Quetiapine Fumarate Sales (MT) by Application (2027–2032)
Table 62. Global Quetiapine Fumarate Sales Market Share by Application (2021–2026)
Table 63. Global Quetiapine Fumarate Sales Market Share by Application (2027–2032)
Table 64. Global Quetiapine Fumarate Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Quetiapine Fumarate Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Quetiapine Fumarate Revenue Market Share by Application (2021–2026)
Table 67. Global Quetiapine Fumarate Revenue Market Share by Application (2027–2032)
Table 68. Global Quetiapine Fumarate Price (USD/Kg) by Application (2021–2026)
Table 69. Global Quetiapine Fumarate Price (USD/Kg) by Application (2027–2032)
Table 70. AstraZeneca Company Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 73. AstraZeneca Quetiapine Fumarate Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Intas Company Information
Table 76. Intas Description and Business Overview
Table 77. Intas Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 78. Intas Quetiapine Fumarate Product
Table 79. Intas Recent Developments/Updates
Table 80. TAPI Company Information
Table 81. TAPI Description and Business Overview
Table 82. TAPI Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 83. TAPI Quetiapine Fumarate Product
Table 84. TAPI Recent Developments/Updates
Table 85. Accord Company Information
Table 86. Accord Description and Business Overview
Table 87. Accord Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 88. Accord Quetiapine Fumarate Product
Table 89. Accord Recent Developments/Updates
Table 90. Hexal Company Information
Table 91. Hexal Description and Business Overview
Table 92. Hexal Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 93. Hexal Quetiapine Fumarate Product
Table 94. Hexal Recent Developments/Updates
Table 95. Dr.Reddy's Company Information
Table 96. Dr.Reddy's Description and Business Overview
Table 97. Dr.Reddy's Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 98. Dr.Reddy's Quetiapine Fumarate Product
Table 99. Dr.Reddy's Recent Developments/Updates
Table 100. Lupin Company Information
Table 101. Lupin Description and Business Overview
Table 102. Lupin Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 103. Lupin Quetiapine Fumarate Product
Table 104. Lupin Recent Developments/Updates
Table 105. Sun Pharmaceutical Company Information
Table 106. Sun Pharmaceutical Description and Business Overview
Table 107. Sun Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 108. Sun Pharmaceutical Quetiapine Fumarate Product
Table 109. Sun Pharmaceutical Recent Developments/Updates
Table 110. Hunan Dongting Pharm Company Information
Table 111. Hunan Dongting Pharm Description and Business Overview
Table 112. Hunan Dongting Pharm Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 113. Hunan Dongting Pharm Quetiapine Fumarate Product
Table 114. Hunan Dongting Pharm Recent Developments/Updates
Table 115. SuZhou NO.4 Phamaceutical Factory Company Information
Table 116. SuZhou NO.4 Phamaceutical Factory Description and Business Overview
Table 117. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 118. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product
Table 119. SuZhou NO.4 Phamaceutical Factory Recent Developments/Updates
Table 120. Fuan Pharmaceutical Company Information
Table 121. Fuan Pharmaceutical Description and Business Overview
Table 122. Fuan Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 123. Fuan Pharmaceutical Quetiapine Fumarate Product
Table 124. Fuan Pharmaceutical Recent Developments/Updates
Table 125. Zhejiang Supor Pharmaceuticals Company Information
Table 126. Zhejiang Supor Pharmaceuticals Description and Business Overview
Table 127. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 128. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product
Table 129. Zhejiang Supor Pharmaceuticals Recent Developments/Updates
Table 130. Zhejiang Huahai Pharmaceutical Company Information
Table 131. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 132. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
Table 133. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product
Table 134. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Quetiapine Fumarate Distributors List
Table 138. Quetiapine Fumarate Customers List
Table 139. Quetiapine Fumarate Market Trends
Table 140. Quetiapine Fumarate Market Drivers
Table 141. Quetiapine Fumarate Market Challenges
Table 142. Quetiapine Fumarate Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Quetiapine Fumarate
Figure 2. Global Quetiapine Fumarate Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Quetiapine Fumarate Market Share by Type: 2025 & 2032
Figure 4. Immediate Release Tablets Product Picture
Figure 5. Extended Release Tablets Product Picture
Figure 6. Global Quetiapine Fumarate Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Quetiapine Fumarate Market Share by Application: 2025 & 2032
Figure 8. Adult
Figure 9. Others
Figure 10. Global Quetiapine Fumarate Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Quetiapine Fumarate Market Size (US$ Million), 2021–2032
Figure 12. Global Quetiapine Fumarate Sales (MT), 2021–2032
Figure 13. Global Quetiapine Fumarate Average Price (USD/Kg), 2021–2032
Figure 14. Quetiapine Fumarate Report Years Considered
Figure 15. Quetiapine Fumarate Sales Share by Manufacturers in 2025
Figure 16. Global Quetiapine Fumarate Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Quetiapine Fumarate Players: Market Share by Revenue in Quetiapine Fumarate in 2025
Figure 18. Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Quetiapine Fumarate Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Quetiapine Fumarate Sales Market Share by Country (2021–2032)
Figure 21. North America Quetiapine Fumarate Revenue Market Share by Country (2021–2032)
Figure 22. U.S. Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Quetiapine Fumarate Sales Market Share by Country (2021–2032)
Figure 25. Europe Quetiapine Fumarate Revenue Market Share by Country (2021–2032)
Figure 26. Germany Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Quetiapine Fumarate Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Quetiapine Fumarate Revenue Market Share by Region (2021–2032)
Figure 33. China Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Taiwan Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Indonesia Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Thailand Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Malaysia Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Philippines Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Quetiapine Fumarate Sales Market Share by Country (2021–2032)
Figure 44. Latin America Quetiapine Fumarate Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Quetiapine Fumarate Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Quetiapine Fumarate Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. U.A.E Quetiapine Fumarate Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Quetiapine Fumarate by Type (2021–2032)
Figure 54. Global Revenue Market Share of Quetiapine Fumarate by Type (2021–2032)
Figure 55. Global Quetiapine Fumarate Price (USD/Kg) by Type (2021–2032)
Figure 56. Global Sales Market Share of Quetiapine Fumarate by Application (2021–2032)
Figure 57. Global Revenue Market Share of Quetiapine Fumarate by Application (2021–2032)
Figure 58. Global Quetiapine Fumarate Price (USD/Kg) by Application (2021–2032)
Figure 59. Quetiapine Fumarate Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Ethylene Oxide (EO) Market Research Report 2026
Jan 17, 26
Global Stem Cells Cryopreservation Equipments Market Research Report 2026
Jan 17, 26
Global Selenium-enriched Yeast Market Research Report 2026
Jan 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232